LTD4

Ltd4 is a lipid of Fatty Acyls (FA) class. Ltd4 is associated with abnormalities such as Inflammatory Bowel Diseases, Inflammatory disorder, Asthma, Pneumonia and Allergic asthma. The involved functions are known as inhibitors, Signal Transduction, Cell Survival, antagonists and Phosphorylation. Ltd4 often locates in Membrane, Tissue membrane, Protoplasm, Cytoplasmic matrix and membrane fraction. The associated genes with LTD4 are ALOX5 gene, UMOD gene, P4HTM gene, RAF1 gene and Homologous Gene. The related lipids are Lipopolysaccharides.

Cross Reference

Introduction

To understand associated biological information of LTD4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with LTD4?

LTD4 is suspected in Asthma, Inflammatory Bowel Diseases, Inflammatory disorder, Pneumonia, Allergic asthma, Virus Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with LTD4

MeSH term MeSH ID Detail
Sneezing D012912 6 associated lipids
Seizures D012640 87 associated lipids
Rhinitis D012220 10 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Peptic Ulcer Hemorrhage D010438 4 associated lipids
Respirovirus Infections D010253 3 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Neuralgia D009437 28 associated lipids
Leukemia D007938 74 associated lipids
Influenza, Human D007251 11 associated lipids
Per page 10 20 50 | Total 39

PubChem Associated disorders and diseases

What pathways are associated with LTD4

Lipid pathways are not clear in current pathway databases. We organized associated pathways with LTD4 through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with LTD4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with LTD4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with LTD4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with LTD4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with LTD4?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with LTD4

Download all related citations
Per page 10 20 50 100 | Total 640
Authors Title Published Journal PubMed Link
Forsell PK et al. Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases. 2012 Lipids pmid:22684912
Capra V et al. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. 2007 Med Res Rev pmid:16894531
Kurogi Y Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. 2003 Med Res Rev pmid:12424751
Bellamkonda K et al. The impact of inflammatory lipid mediators on colon cancer-initiating cells. 2015 Mol. Carcinog. pmid:25154976
Shi ZZ et al. Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response. 2001 Mol. Cell. Biol. pmid:11463821
Campos MR et al. Differential kinase requirement for enhancement of Fc gammaR-mediated phagocytosis in alveolar macrophages by leukotriene B4 vs. D4. 2009 Mol. Immunol. pmid:19223078
Capra V et al. Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. 1998 Mol. Pharmacol. pmid:9547367
Kargman S et al. Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells. 1994 Mol. Pharmacol. pmid:8190095
Sarau HM et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. 1999 Mol. Pharmacol. pmid:10462554
Ravasi S et al. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma. 2000 Mol. Pharmacol. pmid:10825389
Nothacker HP et al. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. 2000 Mol. Pharmacol. pmid:11093801
Zhao L et al. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. 2004 Nat. Med. pmid:15322539
Lynch KR et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. 1999 Nature pmid:10391245
Wang XY et al. Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons. 2013 Neurochem. Int. pmid:23318673
Schuhmann MU et al. Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. 2003 Neurol. Res. pmid:12866196
Dudek SM and Friedlander MJ Developmental down-regulation of LTD in cortical layer IV and its independence of modulation by inhibition. 1996 Neuron pmid:8663986
Conroy DM et al. Relaxant effects of pituitary adenylate cyclase activating polypeptide (PACAP) on epithelium-intact and -denuded guinea-pig trachea: a comparison with vasoactive intestinal peptide (VIP). 1995 Neuropeptides pmid:8538872
Tang SS et al. Leukotriene D4 induces cognitive impairment through enhancement of CysLT₁ R-mediated amyloid-β generation in mice. 2013 Neuropharmacology pmid:22982445
Kang KH et al. Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. 2013 Neuropharmacology pmid:23800665
Hoheisel U and Mense S Leukotriene D4 depresses the mechanosensitivity of group III and IV muscle receptors in the rat. 1994 Neuroreport pmid:8025261
Weiss SR et al. Quenching: inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. 1995 Neuroreport pmid:8595196
Nasuhara Y et al. [Acyclovir and guinea-pig airway smooth muscle]. 1995 Nihon Kyobu Shikkan Gakkai Zasshi pmid:7563998
Kohno S [Role of peptide-leukotrienes in bronchial asthma]. 1998 Nippon Yakurigaku Zasshi pmid:9618707
Chiba Y et al. Effects of 1400W, a potent selective inducible NOS inhibitor, on histamine- and leukotriene D4-induced relaxation of isolated guinea pig nasal mucosa. 2006 Nitric Oxide pmid:16442819
Paruchuri S et al. Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells. 2006 Oncogene pmid:16715140
Goto HG et al. Induction of apoptosis in an estrogen-responsive mouse Leydig tumor cell by leukotriene. 2007 Oncol. Rep. pmid:17143502
Park SY et al. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer. 2016 Oncotarget pmid:26824987
Cyrus CB et al. Leukotrienes C4 and D4 increase the ciliary beat frequency in human upper airway mucosa in vitro. 1998 Otolaryngol Head Neck Surg pmid:9560097
Kopp MV et al. Omalizumab (Xolair) in children with seasonal allergic rhinitis: leukotriene release as a potential in vitro parameter to monitor therapeutic effects. 2007 Pediatr Allergy Immunol pmid:17680911
Hougaard C et al. K+ currents activated by leukotriene D4 or osmotic swelling in Ehrlich ascites tumour cells. 2000 Pflugers Arch. pmid:10898529
Hoffmann EK Leukotriene D4 (LTD4) activates charybdotoxin-sensitive and -insensitive K+ channels in ehrlich ascites tumor cells. 1999 Pflugers Arch. pmid:10398854
Diener M and Scharrer E The effect of short-chain fatty acids on Cl- and K+ conductance in rat colonic crypts. 1994 Pflugers Arch. pmid:8052516
Kawashima Y et al. Surface-modified antiasthmatic dry powder aerosols inhaled intratracheally reduce the pharmacologically effective dose. 1998 Pharm. Res. pmid:9833999
Thompson MD et al. A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. 2003 Pharmacogenetics pmid:14515063
Pillai SG et al. A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma. 2004 Pharmacogenetics pmid:15475736
Kagoshima M et al. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. 1997 Pharmacology pmid:9380772
Lieber G et al. Concomitant activity of histamine and cysteinyl leukotrienes on porcine nasal mucosal vessels and nasal inflammation in the rat. 2010 Pharmacology pmid:20453555
Takizawa T et al. Effects of a new antiallergic agent, VUF-K-8788, on experimental asthmatic reactions in guinea pigs. 1999 Pharmacology pmid:10450067
Suzuki S et al. Leukotriene D4 upregulates MUC2 gene transcription in human epithelial cells. 2008 Pharmacology pmid:18176092
Ro JY et al. The inhibitory mechanism of rebamipide on the mediator release in the guinea pig lung mast cells activated with specific antigen-antibody reactions. 2001 Pharmacology pmid:11598424
Ishinaga H et al. Pranlukast inhibits NF-kappaB activation and MUC2 gene expression in cultured human epithelial cells. 2005 Pharmacology pmid:15475658
Tokuyama K et al. Effects of Y-27632, a Rho/Rho kinase inhibitor, on leukotriene D(4)- and histamine-induced airflow obstruction and airway microvascular leakage in guinea pigs in vivo. 2002 Pharmacology pmid:11893899
Xu L et al. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings. 2010 Pharmazie pmid:21105577
Fukuishi N et al. Antiallergic effect of ardisiaquinone A, a potent 5-lipoxygenase inhibitor. 2001 Phytomedicine pmid:11824521
Mizutani N et al. Effect of Ganoderma lucidum on pollen-induced biphasic nasal blockage in a guinea pig model of allergic rhinitis. 2012 Phytother Res pmid:21698671
Smit NP et al. Stimulation of cultured melanocytes in medium containing a serum substitute: Ultroser-G. 1995 Pigment Cell Res. pmid:7540755
Wienkötter N et al. The effect of nigellone and thymoquinone on inhibiting trachea contraction and mucociliary clearance. 2008 Planta Med. pmid:18219598
Provost V et al. Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells. 2012 PLoS ONE pmid:22952702
Lecca D et al. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. 2008 PLoS ONE pmid:18974869
Khaddaj-Mallat R et al. Pro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi. 2016 PLoS ONE pmid:27935998